⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBRX News
ImmunityBio, Inc. Common Stock
Form 8-K
sec.gov
IBRX
FDA Expands ANKTIVA ® Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease
businesswire.com
IBRX
Bronstein, Gewirtz & Grossman, LLC Is Investigating ImmunityBio, Inc. (IBRX) And Encourages Investors to Connect
accessnewswire.com
IBRX
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ImmunityBio, Inc. (IBRX) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
IBRX
Bronstein, Gewirtz & Grossman, LLC Encourages ImmunityBio, Inc. (IBRX) Investors to Inquire about Securities Investigation
accessnewswire.com
IBRX
ImmunityBio to Participate in the Piper Sandler Virtual Oncology Symposium
businesswire.com
IBRX
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ImmunityBio, Inc. (IBRX) And Encourages Investors to Reach Out
accessnewswire.com
IBRX
These High-Voltage Stocks Are Suddenly Impossible to Ignore
globenewswire.com
AMOD
IBRX
NTHI
SDEV
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ImmunityBio, Inc. (IBRX) And Encourages Investors to Reach Out
accessnewswire.com
IBRX
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ImmunityBio, Inc. (IBRX) And Encourages Stockholders to Reach Out
accessnewswire.com
IBRX